RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials.

Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials.

Add to Collection
2020 May-Jun Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Singh, Awadhesh Kumar', 'Singh, Ritu']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2020
Cited by : Not Available

BACKGROUND AND AIMS: Type 2 diabetes confers a differential risk of cardiovascular (CV) disease according to the gender. Whether newly approved anti-diabetic drugs like sodium-glucose co-transport-2 inhibitors (SGLT-2Is) and glucagon-like peptide-1 recept.....

Keywords : ["cardiovascular outcome trial", "cardiovascular outcome", "type diabetes", "systematic review", "receptor agonist", "gender difference", "metaanalysis", "inhibitor"]